Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation.
- Published in:
- Gene Therapy, 2005, v. 12, n. 20, p. 1534, doi. 10.1038/sj.gt.3302564
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2005 AND VI 12 AND IP 20
Results: 8
1
2
‘Survival gene’ Bcl-xl potentiates DNA-raised antitumor immunity.
- Published in:
- Gene Therapy, 2005, v. 12, n. 20, p. 1517, doi. 10.1038/sj.gt.3302584
- By:
- Publication type:
- Article
3
Gene Therapy Progress and Prospects: Reprograming gene expression by trans-splicing.
- Published in:
- Gene Therapy, 2005, v. 12, n. 20, p. 1477, doi. 10.1038/sj.gt.3302596
- By:
- Publication type:
- Article
4
Adeno-associated virus type 4 (AAV4) targets ependyma and astrocytes in the subventricular zone and RMS.
- Published in:
- Gene Therapy, 2005, v. 12, n. 20, p. 1503, doi. 10.1038/sj.gt.3302554
- By:
- Publication type:
- Article
5
Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections.
- Published in:
- Gene Therapy, 2005, v. 12, n. 20, p. 1494, doi. 10.1038/sj.gt.3302568
- By:
- Publication type:
- Article
6
Lentivirus-mediated gene transfer of viral interleukin-10 delays but does not prevent cardiac allograft rejection.
- Published in:
- Gene Therapy, 2005, v. 12, n. 20, p. 1509, doi. 10.1038/sj.gt.3302547
- By:
- Publication type:
- Article
7
The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
- Published in:
- Gene Therapy, 2005, v. 12, n. 20, p. 1526, doi. 10.1038/sj.gt.3302556
- By:
- Publication type:
- Article
8
Gene targeting by ribozyme against TNF-α mRNA inhibits autoimmune arthritis.
- Published in:
- Gene Therapy, 2005, v. 12, n. 20, p. 1486, doi. 10.1038/sj.gt.3302583
- By:
- Publication type:
- Article